Panchawagh, S. Et Al. 2024. COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.. Rheumatology international , vol.44 , 73-80.

Panchawagh, S., Ravichandran, N., Barman, B., Nune, A., Javaid, M., Gracia-Ramos, A. E., ... Day, J.(2024). COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.. Rheumatology international , vol.44, 73-80.

Panchawagh, Suhrud Et Al. "COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.," Rheumatology international , vol.44, 73-80, 2024

Panchawagh, Suhrud Et Al. "COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.." Rheumatology international , vol.44, pp.73-80, 2024

Panchawagh, S. Et Al. (2024) . "COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.." Rheumatology international , vol.44, pp.73-80.

@article{article, author={Suhrud Panchawagh Et Al. }, title={COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.}, journal={Rheumatology international}, year=2024, pages={73-80} }